Table 2 Correlation between the composite VFQ-25 score and visual functions in central retinal vein occlusion.

From: Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion

 

r

P

Composite VFQ-25 score at baseline

Titmus Stereo Test at baseline

−0.450

0.036*

TNO stereotest at baseline

−0.419

0.052

BCVA at baseline

−0.184

0.412

Composite VFQ-25 score 12 months post-treatment

Titmus Stereo Test at 12 months post-treatment

−0.419

0.094

TNO stereotest at 12 months post-treatment

−0.660

0.004*

BCVA at 12 months post-treatment

−0.554

0.021*

Composite VFQ-25 score 12 months post-treatment

Titmus Stereo Test at baseline

−0.482

0.043*

TNO stereotest at baseline

−0.595

0.009*

BCVA at baseline

−0.553

0.017*

  1. * Significant correlations found between the parameters (Spearman rank-correlation test).
  2. BCVA best-corrected visual acuity, VFQ-25 25-item National Eye Institute Visual Function Questionnaire.
Back to article page